MECHANICALLY EXPANDABLE HEART VALVES WITH SEVERAL TYPES OF INTERCONNECTED STRUTS
#602TRANSCATHETER VALVE - SINGLE STENT STRUCTURE WITH FABRIC
#603METHODS TO FOLD AND FORM DELIVERY SYSTEM BALLOONS TO REDUCE THE DEPLOYED THV HEIGHT ASYMMETRY
#604DUAL-FLANGE PROSTHETIC VALVE FRAME
#605PROSTHETIC CARDIAC VALVE SENSOR DEVICES, SYSTEMS, AND METHODS WITH IMAGING
#606SUTURE ANCHOR FOR MINIMALLY INVASIVE HEART VALVE REPAIR
#607METHOD AND APPARATUS FOR TRANSVASCULAR IMPLANTATION OF NEO CHORDAE TENDINAE
#608DEVICE AND METHOD FOR TREATING VASCULAR INSUFFICIENCY
#609HEART VALVE SEALING DEVICES AND DELIVERY DEVICES THEREFOR
#610INTERCOMMISSURAL LEAFLET SUPPORT
#611FASTENERS FOR PERCUTANEOUS DEVICES
#612TRANSCATHETER VEIN FRAME FOR VENOUS INSUFFICIENCY
#613ORTHOPAEDIC IMPLANT SYSTEMS INCLUDING INTERNAL NETWORKS AND METHODS OF REPAIR
#614THREE-DIMENSIONAL SHAPED OBJECT, METHOD FOR MANUFACTURING SAME, AND CONTROL PROGRAM
#615IMPLANT AND A METHOD OF MAKING THE IMPLANT AND A METHOD OF CALCULATING POROSITY OF A POROUS MATERIAL
#616ACETABULAR PROSTHESIS WITH ADJUSTABLE ACETABULAR CUP CAGES
#617METHOD FOR PRODUCING A SLIDING SURFACE ELEMENT, SLIDING SURFACE ELEMENT AND KNEE JOINT ENDOPROSTHESIS
#618UNIVERSAL TIBIAL INSERT WITH ENHANCED MEDIAL CONGRUENCE
#619Shoulder Trial with Flexure
#620METHODS AND DEVICES FOR ALTERING SPINAL LORDOSIS AND/OR KYPHOSIS
#621REVERSIBLY, PROXIMALLY, AND DISTALLY EXPANDABLE SPINAL CAGE
#622LORDOTIC EXPANDABLE FUSION IMPLANT
#623INTERVERTEBRAL SPACER THAT DYNAMICALLY PROMOTES BONE GROWTH
#624DUAL-AXIS ADJUSTABLE SPINAL SYSTEMS AND INTERBODY FUSION DEVICES WITH FIXATION
#625PREPACKAGED SACROILIAC JOINT IMPLANT WITH PREPACKED BONE GROWTH FACTOR
#626INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT LUMBAR
#627Implantable Joint Prosthesis with Integrated Biasing Systems
#628METHOD FOR CONFIGURING A CONTROLLER AND ORTHOPEDIC DEVICE, AND COMPUTER PROGRAM PRODUCT
#629METHOD FOR CONTROLLING AN ARTIFICIAL ORTHOTIC OR PROSTHETIC KNEE JOINT
#630DISTAL LIMB PERFUSION CANNULA STENT & STENT CANNULA COVER
#631WRIST BRACE
#632MEDICAL DEVICE FOR RELAXING SPINE
#633SPLINT DEVICE AND SPLINT SYSTEM COMPRISING SAME
#634SURGICAL PLATFORM SYSTEM
#635OSTOMY PRODUCT WITH ANTI-REFLUX DEVICE
#636POLYMERIC MANDIBULAR ADVANCEMENT DEVICES AND METHODS FOR MAKING AND USING THEM
#637PATIENT CARE SYSTEMS WITH DYNAMIC GATEWAYS
#638MEDICAL ICE SLURRY PRODUCTION AND DELIVERY SYSTEMS AND METHODS
#639APPARATUS AND METHODS OF RETINAL INJECTION
#640SURGICAL RING DESIGN WITH VARYING WALL THICKNESS AND CONSISTENT CROSS-SECTIONAL AREA
#641Surgical Instruments For A Trabeculotomy Procedure
#642ADJUSTABLE LASER PULSE CONTROL
#643LASER PULSE CONTROL WITH SUB-CARRIER MODULATION
#644PERSONALIZATION OF EXCIMER LASER FIBERS
#645PATIENT INTERFACE DEVICE FOR OPHTHALMIC SURGICAL LASER SYSTEM EMPLOYING A CAP FOR LENS CONE HANDLING
#646PATIENT INTERFACE DEVICE FOR OPHTHALMIC SURGICAL LASER SYSTEM EMPLOYING A CAP FOR LENS CONE HANDLING
#647BILATERAL COMPRESSION DEVICE
#648GOGGLE ASSEMBLY
#649INFLATABLE EARPLUG SYSTEM
#650DRESSINGS FOR REDUCED TISSUE INGROWTH
#651METHOD FOR MAKING AN ABSORBENT ARTICLE AND ABSORBENT ARTICLE
#652Dissector/Absorber Device for Surgical Applications
#653MOISTURE DETECTION SYSTEM, METHOD FOR USE OF SYSTEM, AND LAMINATE FOR SYSTEM
#654SANITARY ARTICLE WITH SHAPING ELEMENT
#655ABSORBENT ARTICLE WITH DUAL CORE
#656ABSORBENT ARTICLE
#657TRANSPORT DEVICE
#658LIFTING SYSTEM AND VEHICLE INCLUDING A LIFTING SYSTEM
#659AUTOMATED PATIENT TURNER SYSTEM
#660BED HAVING SNORE CONTROL BASED ON PARTNER RESPONSE
#661PET BED WITH VITAL SIGN MONITORING
#662SUPPORT ASSEMBLY ATTACHABLE TO A PATIENT SUPPORT AND PATIENT SUPPORT HAVING SAME
#663DUAL-STRAP HOISTING DEVICE AND PATIENT LIFT APPARATUS COMPRISING THE SAME
#664PREMATURE INFANT CARE SYSTEM
#665SURGICAL TABLE INCLUDING CABLE TAKE-UP MECHANISM
#666SURGICAL TABLE
#667SPINE PIANO
#668HAND MOTION DETECTION DEVICE AND CONTROL METHOD, REHABILITATION DEVICE AND AUTONOMOUS CONTROL SYSTEM
#669SLIDING DEVICE AND MOTION ASSISTING DEVICE INCLUDING THE SAME
#670SYSTEM FOR ASSISTING MOBILITY-IMPAIRED INDIVIDUAL AND METHODS OF USE
#671Mobility Aid
#672TRAINING APPARATUS
#673ACTIVE COMPRESSION DECOMPRESSION CARDIOPULMONARY RESUSCITATION CHEST COMPRESSION FEEDBACK
#674THERAPEUTIC EYE TREATMENT WITH GASES
#675OFFSHORE PLATORM SLOT RECOVERY TOOL SYSTEM
#676MEDICINE DISPENSER APPARATUS
#677ADJUSTABLE BOTTLE HOLDER AND USE THEREOF
#678ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAME
#679DENTAL COATING COMPOSITION
#680DENTAL CERAMIC COLORING SOLUTION
#681DENTAL COMPOSITION
#682MEDICAL DEVICE SOLUTIONS FOR TREATING DENTAL DISEASE AND METHODS FOR THE TREATMENT OF DENTAL DISEASE
#683EMULSIFIED COMPOSITION FOR SKIN
#684Oral Care Compositions
#685COMPOSITIONS FOR IMPROVED SKIN APPEARANCE AND METHODS OF USE THEREOF
#686Composition for the control of oral malodor compounds
#687ZINC OXIDE PARTICLES, PHOTOSTABLE UV FILTERS, AND METHODS OF USE THEREOF
#688Oral Care Compositions
#689SILICONE-FREE ANTIPERSPIRANT AND DEODORANT COMPOSITIONS
#690TWO-PHASE COMPOSITION COMPRISING AN AQUEOUS PHASE COMPRISING ONE OR MORE POLYOLS AT A CONTENT RANGING FROM 5% TO 30% BY WEIGHT AND AN OILY PHASE COMPRISING NON-SILICONE OILS
#691DYEING COMPOSITION COMPRISING AN ANTHRAQUINONE CATIONIC DIRECT DYE, A POLYOL, AN ANIONIC SURFACTANT AND A NONIONIC POLYSACCHARIDE
#692HAIR CLEANSING COMPOSITION
#693HAIR CARE COMPOSITION
#694COMPOSITION FOR SUPPRESSING SKIN IRRITATION OR INHIBITING SEBUM SECRETION
#695COMPOSITION FOR PROMOTING THE SKIN MICROBIOME
#696COMPOSITION FOR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH COMPRISING GROWTH FACTOR
#697COMPOSITIONS COMPRISING COMBINATIONS OF COLLAGEN OR ELASTIN POLYPEPTIDES WITH ACTIVE INGREDIENTS AND METHODS OF USING SAME
#698TOOTH ANTI-STAINING COMPOSITION, KIT AND METHOD OF USING THE SAME
#699CRYSTAL INFUSED FEMININE HYGIENE WASHES
#700COMPOSITIONS, METHODS, AND KITS FOR CLEANSING AND MOISTURIZING
#701STABLE COMPOSITIONS CONTAINING A CANNABINOID
#702Sunscreen Compositions and Methods of Use
#703COMPOSITION FOR TREATING OR PREVENTING SKIN PIGMENTATION
#704ADMINISTRATION OF A PSYCHEDELIC COMPOUND
#705N-ACETYLCYSTEINE COMPOSITIONS AND METHODS
#706Implantable Medical Device for the Delivery of an Antipsychotic
#707INTRANASAL DELIVERY OF OLANZAPINE BY PRECISION OLFACTORY DEVICE
#708METHOD FOR ALLEVIATING DRY EYE SYNDROME
#709STABLE OPHTHALMIC COMPOSITION OF LOTEPREDNOL
#710STABLE ORAL DISPERSIBLE FORMULATION FOR EPINEPHRINE
#711SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND METHODS OF MAKING THEREOF
#712PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
#713INTRACRANIAL DRUG DELIVERY MATERIALS AND METHODS
#714BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#715SYSTEMS FOR VACUUM MEDIATED LIPOSOME PREPARATION, AND METHODS FOR USING THE SAME
#716Multi-targeting cell-derived nanoparticles as a versatile theranostic
#717HYDROXYPROPYL METHYL CELLULOSE DERIVATIVES TO STABILIZE POLYPEPTIDES
#718Sorafenib particles and uses thereof
#719NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION
#720DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME
#721STABILIZED FORMULATIONS OF LIPID NANOPARTICLES
#722PROTEIN-RELEASE SYSTEM FOR SUSTAINED RELEASE OF PROTEINS
#723STABILIZED SOLID NANOPARTICLE FORMULATIONS OF CANNABINOIDS AND CANNABINOID ANALOGS WITH REDUCED OSTWALD RIPENING FOR ORAL, INHALATION, NASAL AND PARENTERAL DRUG DELIVERY
#724Compositions Comprising (Bio)-Alkanediols with Antimicrobials for Product Protection
#725TREATMENT OF AUTISM WITH CANNABIDIOL
#726POLYMORPHIC FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE
#727PARENTERAL TREATMENTS INVOLVING AMINOADAMANTANE DERIVATIVES
#728TREATMENT OF BRAIN COPPER DISORDERS
#729USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS
#730COMPOUNDS FOR TREATING VIRUS INFECTIONS
#731METHODS OF INHIBITING DISEASES CAUSED BY RESPIRATORY VIRUSES
#732FLUOROPHENYL BETA-HYDROXYETHYLAMINES AND THEIR USE IN THE TREATMENT OF HYPERGLYCAEMIA
#733EPINEPHRINE SPRAY FORMULATIONS
#734CANCER THERAPEUTIC
#735ANTI-INFECTIVE DOSAGE FORMS FOR PRODUCING A NASAL RINSE
#736Methods of Managing Side Effects of a Vasopressin Receptor Antagonist Therapy
#737EARLY ADMINISTRATION OF LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION
#738USE OF PARABULIN FOR TARGETING PROTOZOAN TUBULIN FOR THE INHIBITION OF PROTOZOAN REPLICATION
#739ADMINISTRATION OF BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN HUMANS FOR THE TREATMENT AND/OR PREVENTION OF RESPIRATORY ILLNESSES
#740C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION
#741Methods of Treating or Preventing Acute Respiratory Distress Syndrome
#742REACTIVATION OF mTOR IN ACUTE KIDNEY INJURY (AKI)
#743USE OF ESTER GROUP-CONTAINING AROMATIC PROPIONAMIDE COMPOUND IN PREPARATION OF MEDICINE FOR TREATING DRY EYE SYNDROME
#744COMPOSITIONS COMPRISING N-ACETYL METHYL GABA AND RELATED METHODS
#745COMBINATION OF P2Y6 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS
#746METHOD FOR TREATMENT OF ROSACEA INCLUDING PATIENT REPORTED OUTCOMES THEREOF
#747FORMULATIONS AND METHODS FOR IMPROVING AVIAN HEALTH
#748COMPOSITION AND METHOD FOR TREATING AUTISM
#749PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PROSTATE CANCER OR BREAST CANCER
#750METHODS FOR TREATING COVID-19
#751METHODS OF IMPROVING RENAL FUNCTION
#752BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#753PSILOCIN PRODRUG COMPOUNDS AND METHODS OF SYNTHESIZING THE SAME
#754STABLE PHARMACEUTICAL COMPOSITION
#755METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS
#756THIAZOLIDINE DERIVATIVES FOR INHIBITING CAV3.2-USP5 INTERACTIONS
#757METHOD OF TREATING MYELOID MALIGNANCIES
#758ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME
#759USE OF TETRANDRINE IN COMBINATION WITH ALL-TRANS RETINOIC ACID IN PREPARATION OF MEDICAMENT FOR TREATING PNEUMOCONIOSIS
#760ANTIBIOTIC COMBINATION THERAPIES
#761TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA HALF- LIFE
#762ANTIFUNGAL AGENTS WITH ENHANCED ACTIVITY IN ACIDIC PH
#763Nimodipine Parenteral Administration
#764METHOD FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS THROUGH CO-ADMINISTRATION OF CURCUMIN DERIVATIVE AND TGF-B RECEPTOR INHIBITOR
#765PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER
#766Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones
#767COMPOSITIONS AND METHODS FOR TREATING RHEUMATOID ARTHRITIS
#768PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES
#769Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting
#770MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE
#771USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SULPHATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS
#772COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES
#773METHOD OF PREPARING NANOPARTICLES COMPRISING POORLY WATER SOLUBLE DRUGS FOR TREATING HEPATITIS
#774COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
#775TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH UPADACITINIB
#776METHOD AND FORMULATION FOR TREATING MALE PREMATURE EJACULATION
#777MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
#778HISTONE DEACETYLASE 6 (HDAC6) BIOMARKERS IN MULTIPLE MYELOMA
#779METHODS FOR PREVENTING OR TREATING CONDITIONS RELATED TO PIKFYVE ACTIVITY
#780USE OF MODULATORS OF CCR5 IN THE TREATMENT OF CANCER AND CANCER METASTASIS
#781COMBINATION THERAPIES WITH EHMT2 INHIBITORS
#782THERAPEUTIC TARGETING OF ACTIVATED AVIL-INDUCED SARCOMAS
#783USE OF FAK INHIBITOR IN PREPARATION OF DRUG FOR TREATING TUMORS HAVING NRAS MUTATION
#784COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION
#785FORMULATIONS/COMPOSITIONS COMPRISING A BTK INHIBITOR
#786COMPOSITIONS AND METHODS FOR TREATING CANCER
#787SOLID FORMS OF A TOLL-LIKE RECEPTOR MODULATOR
#788PHARMACEUTICAL COMPOSITION CONTAINING PALBOCICLIB AND LETROZOLE
#789DEUTERATED RUC-4
#790TOPICAL TREATMENT OF VITILIGO
#791USE OF A COMBINATION COMPRISING A BTK INHIBITOR FOR TREATING CANCERS
#792TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#793HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATION
#794SOLID STATE FORMS OF RESMETIROM
#795METHODS OF TREATING PDE IV-MEDIATED DISEASES OR CONDITIONS
#796DICLOFENAC PRODRUG AND USE OF THE SAME
#797COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#798PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF HUMAN HYPOCHOLINERGIC DISORDERS
#799SULFONAMIDE OR SULFINAMIDE COMPOUND HAVING EFFECT OF INDUCING BRD4 PROTEIN DEGRADATION AND PHARMACEUTICAL USE THEREOF
#800PARENTERAL DOSAGE FORM OF DILTIAZEM
#801PHARMACEUTICAL COMPOSITIONS COMPRISING A RYANODINE RECEPTOR MODULATOR AND USES THEREOF
#802NEFOPAM DOSAGE FORMS AND METHODS OF TREATMENT
#803GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUS
#804METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#805METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#806Use of Antcin H and Its Derivatives for Treating Central Nervous System Diseases
#807PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES TO THE RECTUM
#808PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF USING THEREOF
#809NOVEL PSYCHEDELIC COMPOSITIONS, DELIVERY SYSTEMS AND THERAPEUTIC USES THEREOF
#810PARENTERAL NUTRITION FORMULATION AND METHODS OF PREPARATION THEREOF
#811BRAIN HEALTH SUPPLEMENTS
#812RIBITOL TREATMENT
#813AUTOPHAGY ACTIVATOR
#814NIRAN INTERFERING DRUGS FOR SARS-COV-2 MUTANT THERAPY
#815METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS
#816METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS
#817METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES
#818CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS
#819EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6
#820TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION
#821TOPICAL COMPOSITIONS
#822INHALED ARGON FOR TREATING A PATIENT SUFFERING FROM CARDIOVASCULAR DISEASE
#823GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL ISCHEMIC STROKES
#824GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL STROKES
#825DIETARY SUPPLEMENT COMPOSITIONS
#826METHOD FOR IMPROVING HEALTH CONDITIONS
#827GUT-SELECTIVE SEQUESTERING AGENTS FOR THE TREATMENT AND PREVENTION OF AUTISM AND RELATED DISORDERS
#828T lymphocyte and applications thereof
#829CHIMERIC ANTIGEN RECEPTOR EXPRESSION SYSTEMS
#830ENGINEERED T CELLS FOR EXPRESSION OF CHIMERIC ANITGEN RECEPTORS
#831METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA
#832T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF
#833TGFBETA SIGNAL CONVERTOR
#834COMPOSITION FOR ANTIVIRUS COMPRISING NATURAL KILLER CELL
#835PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION
#836STIMULATION OF OVARIAN FUNCTION SUBSEQUENT TO CHEMOTHERAPY AND/OR RADIATION THERAPY USING NATURAL KILLER CELLS
#837Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of Autoimmune Disease
#838COMPOSITIONS AND METHODS FOR CD30 GENE MODIFICATION
#839METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS
#840INHIBITION AND REVERSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ENDOTHELIAL CELL REGENERATION
#841METHOD FOR TREATING HEART FAILURE
#842METHOD FOR ISOLATION AND PURIFICATION OF MICROVESICLES FROM CELL CULTURE SUPERNATANTS AND BIOLOGICAL FLUIDS
#843COMPOSITIONS AND METHODS OF USE FOR INFUSIBLE EXTRACELLULAR MATRIX
#844METHOD FOR DIRECT REPROGRAMMING FROM SOMATIC CELLS INTO PANCREATIC BETA CELLS BY USING MICRORNA, AND DIFFERENTIATION COMPOSITION
#845METHODS AND ARTICLES OF MANUFACTURE FOR ANIMAL THERAPEUTICS
#846FETAL SUPPORT TISSUE PRODUCTS AND METHODS OF USE
#847TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS
#848KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA
#849METHODS AND MATERIALS FOR TREATING GASTROINTESTINAL DISORDERS
#850MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE
#851METHOD FOR TREATING PARKINSON’S DISEASE BY USING PARABACTEROIDES GOLDSTEINII
#852METHODS AND COMPOSITIONS OF BIOCONTROL OF PLANT PATHOGENS
#853METHODS AND COMPOSITIONS FOR INTESTINAL INFLAMMATION
#854ENHANCEMENT OF ANTITUMOR EFFECT OF IMMUNE CHECKPOINT INHIBITOR THROUGH ADMINISTRATION OF INTESTINAL RUMINOCOCCACEAE BACTERIUM
#855FECAL MATTER FOR PREVENTING OR TREATING INTESTINAL MICROBIOME ABERRATIONS IN CESAREAN SECTION-BORN INFANTS
#856METHODS AND COMPOSITIONS TO MODULATE ANTIBIOTIC RESISTANCE AND GASTROINTESTINAL MICROBIOTA
#857APPLICATION OF POSTBIOTICS OF INACTIVATED LACTOBACILLUS CASEI IOB-P9 IN BLOOD GLUCOSE REDUCING
#858ONCOLYTIC VACCINIA VIRUS DEFICIENT IN LARGE REGION OF GENES
#859COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSE
#860USE OF ANTRODIA CINNAMOMEA FOR INCREASING ALCOHOL METABOLISM OR/AND HANGOVER
#861COMPOSITION FOR PREVENTING OR TREATING OBESITY OR DIABETES, COMPRISING ACANTHOPANAX SENTICOSUS EXTRACT AND GARCINIA CAMBOGIA EXTRACT OR COMPOUND ISOLATED THEREFROM
#862SENSORY MODIFIER COMPOUNDS
#863MODULATION OF SOLUBILITY, PALATABILITY, ABSORPTION, AND BIOAVAILABILITY OF MITRAGYNA SPECIOSA-DERIVED COMPOUNDS FOR ORAL AND BUCCAL DELIVERY
#864SYNERGISTIC HERBAL COMPOSITIONS FOR IMMUNITY, COLD AND COUGH
#865METHOD FOR PRODUCING EXTRACT COMPOSITION
#866HERBAL COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME
#867ANTI-INFLAMMATORY FORMULATION-COATED TRANSDERMAL PATCH
#868PROCESS FOR ENHANCING ORGANOLEPTIC PROPERTIES OF NATURAL PRODUCTS AND NATRACEUTICALS THEREOF
#869Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells
#870INHIBITION OF TREM RECEPTOR SIGNALING WITH PEPTIDE VARIANTS
#871COMPOSITION FOR IMPROVING MILD COGNITIVE IMPAIRMENT AND METHOD FOR IMPROVING MILD COGNITIVE IMPAIRMENT
#872TREATMENT OF HMGB1-MEDIATED INFLAMMATION
#873Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
#874CARTILAGE-HOMING PEPTIDES
#875RESPIRATORY VIRUS THERAPEUTIC COMPOSITIONS AND METHODS OF PREPARATION AND USE
#876VEGFR Fusion Protein Pharmaceutical Composition
#877METHOD OF TREATING OR AMELIORATING A PATHOGENIC INFECTION BY ADMINISTERING AN INTERLEUKIN-2/TGF-BETA RECEPTOR FUSION POLYPEPTIDE
#878COMPOSITION INCLUDING PLGF FOR PREVENTION OR TREATMENT OF NEUROPSYCHOLOGIC DISEASE
#879PHARMACEUTICAL COMPOSITION FOR OTIC ADMINISTRATION
#880Method to Improve Neurologic Outcomes in Temperature Managed Patients
#881USE OF BMP9 IN COMBINATION WITH NK CELL AND PD-L1 ANTIBODY IN PREPARING MEDICAMENT FOR TREATING LIVER CANCER
#882COMPOSITIONS AND METHODS FOR PERSONALIZED TREATMENT OF NEURODEGENERATIVE CONDITIONS OR SIDE EFFECTS THEREOF
#883MODULATION OF BETA CELL REGENERATION THROUGH GPR75 SIGNALING
#884COMBINED DRUG FOR TREATING CORONARIVUS DISEASE 2019
#885GLP-1R/GCGR Dual Target Agonist Polypeptide Derivative for Treatment of Hepatic Fibrosis Associated with Viral Hepatitis
#886METHODS FOR TREATING GRAFT-VERSUS-HOST DISEASE USING GLP-2 AGONISTS AND ANALOGUES THEREOF
#887C-Peptide as a Therapy for Patients with Diabetes
#888IMPROVEMENT OF PHYSICAL AND MENTAL WELL-BEING OF PATIENTS WITH HYPOPARATHYROIDISM
#889GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS
#890PHARMACEUTICAL COMPOSITION CONTAINING INSULIN-LIKE GROWTH FACTOR-2 AND USE THEREOF
#891MICROPARTICLE-BASED ENZYME SYSTEMS FOR SELECTIVE REMOVAL OF TARGET MOLECULES
#892New Granules for Animal Feed
#893Bioactive Peptides, Compositions, Production Process, and Use of Bioactive Peptides as Anti-Tumoral Agents
#894COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL CANCER
#895GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE
#896MUTANT OF IMMUNOGLOBULIN DEGRADING ENZYME IDEE
#897EFFECTIVE DOSAGE OF RECOMBINANT SERPIN-FC FUSION PROTEIN FOR USE IN A METHOD OF TREATING AAT DEFICIENCY IN A SUBJECT
#898IMMUNOGENIC SCHISTOSOMA COMPOSITIONS
#899ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE
#900NUCLEOTIDE SEQUENCE EXPRESSING AN EXOSOME-ANCHORING PROTEIN FOR USE AS VACCINE